Cite

HARVARD Citation

    Lipplaa, A. et al. (2019). Adjuvant Zoledronic Acid in High‐Risk Giant Cell Tumor of Bone: A Multicenter Randomized Phase II Trial. Oncologist. pp. 889-e421. [Online]. 
  
Back to record